These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 6286546)

  • 1. In vitro studies on the absorption of WR-2721 by tumors and normal tissues.
    Ritter MA; Brown DQ; Glover DJ; Yuhas JM
    Int J Radiat Oncol Biol Phys; 1982; 8(3-4):523-6. PubMed ID: 6286546
    [No Abstract]   [Full Text] [Related]  

  • 2. Distribution of 35S-labeled WR-2721 in normal and malignant tissues of the mouse1,2.
    Utley JF; Marlowe C; Waddell WJ
    Radiat Res; 1976 Nov; 68(2):284-91. PubMed ID: 185642
    [No Abstract]   [Full Text] [Related]  

  • 3. Circumvention of the tumor membrane barrier to WR-2721 absorption by reduction of drug hydrophilicity.
    Yuhas JM; Davis ME; Glover D; Brown DQ; Ritter M
    Int J Radiat Oncol Biol Phys; 1982; 8(3-4):519-22. PubMed ID: 6286545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Active versus passive absorption kinetics as the basis for selective protection of normal tissues by S-2-(3-aminopropylamino)-ethylphosphorothioic acid.
    Yuhas JM
    Cancer Res; 1980 May; 40(5):1519-24. PubMed ID: 6245795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of WR-1065 in mouse tissue following treatment with WR-2721.
    Utley JF; Seaver N; Newton GL; Fahey RC
    Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1525-8. PubMed ID: 6090355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variation in normal tissue responsiveness to WR-2721.
    Yuhas JM; Afzal SM; Afzal V
    Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1537-9. PubMed ID: 6090357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of WR-2721 in radiotherapy and/or chemotherapy.
    Yuhas JM; Spellman JM; Culo F
    Cancer Clin Trials; 1980; 3(3):211-6. PubMed ID: 6254681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the protective effects of three phosphorothioate radioprotectors in the RIF-1 tumor.
    Rasey JS; Krohn KA; Magee S; Nelson N; Chin L
    Radiat Res; 1986 Nov; 108(2):167-75. PubMed ID: 3024202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distribution of WR-2721 in normal and malignant tissues of mice and rats bearing solid tumors: dependence on tumor type, drug dose and species.
    Washburn LC; Carlton JE; Hayes RL
    Radiat Res; 1974 Aug; 59(2):475-83. PubMed ID: 4371539
    [No Abstract]   [Full Text] [Related]  

  • 10. In vitro metabolism of the phosphorothioate radioprotectors WR-2721 and WR-3689.
    Livesey JC; Rasey JS; Vertrees S; Freeman LM; Magee S; Nelson NJ; Chin L; Grunbaum Z; Krohn KA
    Pharmacol Ther; 1988; 39(1-3):215-7. PubMed ID: 2849127
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacokinetics of WR-2721.
    Shaw LM; Glover D; Turrisi A; Brown DQ; Bonner HS; Norfleet AL; Weiler C; Glick JH; Kligerman MM
    Pharmacol Ther; 1988; 39(1-3):195-201. PubMed ID: 2849123
    [No Abstract]   [Full Text] [Related]  

  • 12. In vivo dephosphorylation of WR-2721 monitored by 31P NMR spectroscopy.
    Knizner SA; Jacobs AJ; Lyon RC; Swenberg CE
    J Pharmacol Exp Ther; 1986 Jan; 236(1):37-40. PubMed ID: 3001292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transplacental uptake of WR 2721 by the rat embryo.
    Davis ME; Conger AD; Sodicoff M
    Int J Radiat Oncol Biol Phys; 1987 Apr; 13(4):575-8. PubMed ID: 3030982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human pharmacokinetics of WR-2721.
    Shaw LM; Turrisi AT; Glover DJ; Bonner HS; Norfleet AL; Weiler C; Kligerman MM
    Int J Radiat Oncol Biol Phys; 1986 Aug; 12(8):1501-4. PubMed ID: 3019968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uptake of WR-2721 derivatives by cells in culture: identification of the transported form of the drug.
    Calabro-Jones PM; Aguilera JA; Ward JF; Smoluk GD; Fahey RC
    Cancer Res; 1988 Jul; 48(13):3634-40. PubMed ID: 2837319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radioprotection of normal tissues against gamma rays and cyclotron neutrons with WR-2721: LD50 studies and 35S-WR-2721 biodistribution.
    Rasey JS; Nelson NJ; Mahler P; Anderson K; Krohn KA; Menard T
    Radiat Res; 1984 Mar; 97(3):598-607. PubMed ID: 6328565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, biodistribution, and autoradiography of radiolabeled S-2-(3-methylaminopropylamino)ethylphosphorothioic acid (WR-3689).
    Rasey JS; Krohn KA; Grunbaum Z; Spence AM; Menard TW; Wade RA
    Radiat Res; 1986 Jun; 106(3):366-79. PubMed ID: 3012625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Studies on the radioprotective effects of YM-08310 (= WR-2721) Part 1: Radioprotective effects of YM-08310 on normal and malignant tissues in mice].
    Tanaka Y; Akagi K; Hasegawa T; Nakazawa M; Harima K; Murata T; Sawada S
    Nihon Igaku Hoshasen Gakkai Zasshi; 1983 May; 43(5):700-9. PubMed ID: 6312407
    [No Abstract]   [Full Text] [Related]  

  • 19. Dephosphorylation of WR-2721 with mouse tissue homogenates.
    Mori T; Nikaido O; Sugahara T
    Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1529-31. PubMed ID: 6090356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy testing of WR-2721 in Great Britain everything is black and white at the gray lab.
    Yuhas JM
    Int J Radiat Oncol Biol Phys; 1983 Apr; 9(4):595-8. PubMed ID: 6303993
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.